Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in MNKD — Mannkind Corp

CIK 1423053 MIAMI, FL
Back to MNKD Full portfolio

Position in MNKD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,916,555
-$17,336,429 QoQ
Shares Held
1,190,431
-66.7% QoQ
Ownership
0.385%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MNKD Over Time

Shares Held

Position Value (USD)

Derivatives in MNKD

reported options exposure · as of Mar 31, 2026
CallValue
$312,130
CallShares
127,400
PutValue
$755,090
PutShares
308,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,537,601 across 374 Biotechnology names. MNKD ranks #171 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in MNKD

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $312,130 127,400
2026-03-31 $755,090 308,200
2026-03-31 $2,916,555 1,190,431
2025-12-31 $1,306,368 230,400
2025-12-31 $725,760 128,000
2025-12-31 $20,252,984 3,571,955
2025-09-30 $6,983,990 1,300,557
2025-09-30 $866,718 161,400
2025-09-30 $956,397 178,100
2025-06-30 $291,720 78,000
2025-06-30 $693,747 185,494
2025-06-30 $498,542 133,300
2025-03-31 $321,920 64,000
2025-03-31 $562,354 111,800
2025-03-31 $1,664,804 330,975
2024-12-31 $3,297,721 512,865
2024-12-31 $884,125 137,500
2024-12-31 $1,724,526 268,200
2024-09-30 $7,116,398 1,131,383
2024-09-30 $1,133,458 180,200
2024-09-30 $642,209 102,100
2024-06-30 $1,292,472 247,600
2024-06-30 $335,646 64,300
2024-06-30 $8,894,832 1,703,991
2024-03-31 $922,761 203,700
2024-03-31 $4,524,826 998,858
2024-03-31 $938,616 207,200
2023-12-31 $160,524 44,100
2023-12-31 $644,644 177,100
2023-12-31 $3,731,422 1,025,116
2023-09-30 $398,958 96,600
2023-09-30 $312,228 75,600
2023-09-30 $7,633,304 1,848,258
2023-06-30 $5,695,675 1,399,429
2023-06-30 $276,353 67,900
2023-06-30 $274,725 67,500
2023-03-31 $273,880 66,800
2023-03-31 $11,468,310 2,797,149
2023-03-31 $309,550 75,500
2022-12-31 $21,868,928 4,149,702
2022-12-31 $880,617 167,100
2022-12-31 $690,370 131,000
2022-09-30 $4,543,545 1,470,403
2022-09-30 $645,501 208,900
2022-09-30 $494,400 160,000
2022-06-30 $821,817 215,700
2022-06-30 $2,756,405 723,466
2022-06-30 $1,832,991 481,100
2022-03-31 $4,378,235 1,189,738
2022-03-31 $404,800 110,000

Report a Problem

Category
Description
Email (optional, for follow-up)